Catalyst Wire Dossier Catalyst Wire Dossier

Botulinum toxin type A topical gel

botulinum toxin type A topical gel · Revance Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Botulinum toxin type A topical gel, covering 2016-08-04 to 2016-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines [Phase 3]

See pricing